Celon Pharma S.A.
PolandAll drugs from this manufacturer
-
The medicinal product is intended for the symptomatic treatment of mild to moderate dementia occurring in Alzheimer's disease.
Dosage form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 5 mg ATC: N06DA02
-
The medicine is intended for the symptomatic treatment of mild to moderate dementia in Alzheimer's disease.
Dosage form: tablets, film-coated
Active substance Dosage donepezil hydrochloride monohydrate 10 mg ATC: N06DA02
-
It is used in the treatment of schizophrenia, depressive episodes in bipolar disorder, and mania.
Dosage form: tablets, film-coated
Active substance Dosage quetiapine fumarate 25 mg ATC: N05AH04
-
The medicine is used in the treatment of schizophrenia, depressive episodes in bipolar disorder, and mania.
Dosage form: tablets, film-coated
Active substance Dosage quetiapine fumarate 100 mg ATC: N05AH04
-
The medicine is used in the treatment of schizophrenia, depressive episodes in bipolar disorder, and mania.
Dosage form: tablets, film-coated
Active substance Dosage quetiapine fumarate 200 mg ATC: N05AH04
-
It is used in adults who had a heart attack more than a year ago. The medicine is intended to reduce the risk of another heart attack, stroke, or death from cardiovascular causes.
Dosage form: capsules, hard
Active substance Dosage ticagrelor 60 mg ATC: B01AC24
-
The medicine is used in adults who have experienced a heart attack or unstable angina. It helps to reduce the risk of another heart attack, stroke, or death from cardiovascular causes.
Dosage form: capsules, hard
Active substance Dosage ticagrelor 90 mg ATC: B01AC24
-
The medicine is used to treat high blood pressure in adults as well as in children and adolescents (6–18 years), in adults following a recent heart attack, and in the treatment of symptomatic heart failure in adults.
Dosage form: tablets
Active substance Dosage valsartan 80 mg ATC: C09CA03
-
The medicine is used to treat high blood pressure in adults and in children and adolescents (from 6 to 18 years), in adults following a recent heart attack, and in the treatment of symptomatic heart failure in adults.
Dosage form: tablets
Active substance Dosage valsartan 160 mg ATC: C09CA03
-
ZARIXA is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01
-
ZARIXA is used in adults to prevent the formation of blood clots in the veins after hip or knee replacement surgery, to treat deep vein thrombosis and pulmonary embolism, and to prevent their recurrence.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
ZARIXA is used in adults to prevent strokes and other blood clots (e.g., in atrial fibrillation) and to treat and prevent blood clots in the leg and lung veins. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent blood clots in the veins or lungs following initial injectable treatment.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation), as well as to treat and prevent clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent clots in the veins or lungs following initial injectable treatment.
Dosage form: capsules, hard
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01